Cargando…
QuilA® adjuvanted Coxevac® sustains Th1-CD8(+)-type immunity and increases protection in Coxiella burnetii-challenged goats
Coxevac® is the EMA-approved veterinary vaccine for the protection of cattle and goats against Q fever, a zoonotic bacterial disease due to Coxiella burnetii. Since Coxevac® reduces bacterial shedding and clinical symptoms but does not prevent infection, novel, ready-to-use vaccine formulations are...
Autores principales: | Tomaiuolo, Sara, Jansen, Wiebke, Soares Martins, Susana, Devriendt, Bert, Cox, Eric, Mori, Marcella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929268/ https://www.ncbi.nlm.nih.gov/pubmed/36788233 http://dx.doi.org/10.1038/s41541-023-00607-z |
Ejemplares similares
-
QuilA-Adjuvanted T. gondii Lysate Antigens Trigger Robust Antibody and IFNγ(+) T Cell Responses in Pigs Leading to Reduction in Parasite DNA in Tissues Upon Challenge Infection
por: Rahman, Mizanur, et al.
Publicado: (2019) -
Phylogeography of Human and Animal Coxiella burnetii Strains: Genetic Fingerprinting of Q Fever in Belgium
por: Tomaiuolo, Sara, et al.
Publicado: (2021) -
FML/QuilA-Vaccinated Dogs Naturally Infected with Leishmania infantum: Serum Cytokines, Clinicopathological Profile, and Parasitological Parameters
por: Almeida, Gregório Guilherme, et al.
Publicado: (2021) -
Role of Goats in the Epidemiology of Coxiella burnetii
por: Anastácio, Sofia, et al.
Publicado: (2022) -
Low seroprevalence of Coxiella burnetii in Boer goats in Missouri
por: Baker, Molly D, et al.
Publicado: (2014)